4/A

OWNERSHIP DOCUMENT

Company: Cadrenal Therapeutics, Inc.
Filed: March 24, 2025
Period of Report: January 23, 2025
Accession Number: 0001013762-25-001779

View Document ↗ View on SEC.gov ↗